Refining the gut colonization Zophobas morio larvae model using an oral administration of multidrug-resistant Escherichia coli

Yasmine Eddoubaji,Claudia Aldeia,Dierik H. Heg,Edgar I. Campos-Madueno,Andrea Endimiani
DOI: https://doi.org/10.1016/j.jgar.2024.10.262
IF: 4.349
2024-11-04
Journal of Global Antimicrobial Resistance
Abstract:Background The darkling beetle Zophobas morio can be implemented as an alternative in vivo model to study different intestinal colonization aspects. Recently, we showed that its larvae can be colonized by multidrug-resistant Escherichia coli strains administered via contaminated food (for 7 days) for a total experimental duration of 28 days. Method In the present work, we aimed to shorten the model to 14 days (T14) by administering the previously used CTX-M-15 ESBL-producing ST131 Escherichia coli strain Ec -4901.28 via a single oral administration (5 μL dose of 10 8 CFU/mL) , using a blunt 26s-gauge needle connected to a 250 μL gastight syringe. Force-feeding was performed either without or with (larvae placed on ice for 10 minutes before injection) anesthesia. In addition, phage-treated larvae were orally injected with 10 μL of INTESTI bacteriophage cocktail (∼10 5-6 PFU/mL) on days 4 (T4) and 7 (T7) . Results Growth curve analyses showed that, while larvae rapidly became colonized with Ec -4901.28 (T1, ∼10 6-7 CFU/mL) , only those anesthetized maintained a high bacterial load (∼10 2-3 vs . ∼10 5-6 CFU/mL) and survival rate (76% vs . 99%; P<0.001) by T14. Moreover, bacteriophage administration to anesthetized larvae significantly reduced the bacterial count of INTESTI -susceptible Ec -4901.28 at T14 (5.17 × 10 5 vs . 2.26 × 10 4, for non-treated and phage-treated larvae, respectively; P=0.04) . Conclusion The methodological refinements applied to establish the intestinal colonization model simplify the use of Z. morio larvae, facilitate prompt evaluation of novel decolonization approaches and reduce experiments involving vertebrate animals in accordance with the Replacement, Reduction and Refinement principles.
pharmacology & pharmacy,infectious diseases
What problem does this paper attempt to address?